[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100422526":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":31,"centralContacts":36,"locations":45,"responsibleParty":64,"collaborators":66,"id":70,"slug":71,"hasResults":72,"nctId":73,"briefTitle":74,"officialTitle":74,"acronym":26,"eligibilityCriteria":75,"healthyVolunteers":72,"sex":76,"minAge":77,"maxAge":78,"enrollmentInfo":79,"targetDuration":26,"studyType":82,"phases":83,"briefSummary":85,"conditions":86,"keywords":26,"overallStatus":47,"whyStopped":26,"lastUpdateSubmitDate":88,"lastUpdatePostDateStruct":89,"startDateStruct":92,"completionDateStruct":94,"leadSponsor":96,"locationsCount":97},{"fullName":5,"class":6},"Johns Hopkins University","OTHER",[8,15],{"label":9,"type":10,"description":11,"interventionNames":12},"Methylphenidate first","EXPERIMENTAL","Single oral dose of methylphenidate (10mg or 15 mg) and then matching placebo after washout period of one week.",[13,14],"Drug: Methylphenidate","Drug: Placebo",{"label":16,"type":17,"description":18,"interventionNames":19},"Placebo first","PLACEBO_COMPARATOR","Matching placebo and then single oral dose of methylphenidate (10mg or 15 mg) after washout period of one week.",[13,14],[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DRUG","Methylphenidate","single dose of 10 mg or 15 mg",[9,16],null,{"type":22,"name":28,"description":29,"armGroupLabels":30,"otherNames":26},"Placebo","Matching placebo",[9,16],[32],{"name":33,"affiliation":34,"role":35},"Kristin L Bigos, PhD","Johns Hopkins School of Medicine","PRINCIPAL_INVESTIGATOR",[37,41],{"name":33,"role":38,"phone":39,"phoneExt":26,"email":40},"CONTACT","410-614-0453","kbigos1@jhu.edu",{"name":42,"role":38,"phone":43,"phoneExt":26,"email":44},"Robyn Wiseman, BS","304-551-3309","rwisema5@jhmi.edu",[46],{"facility":34,"status":47,"city":48,"state":49,"zip":50,"country":51,"countryCode":52,"cosmosGeoPoint":53,"geoPoint":58,"contacts":59},"RECRUITING","Baltimore","Maryland","21205","United States","US",{"type":54,"coordinates":55},"Point",[56,57],-76.61219,39.29038,{"lat":57,"lon":56},[60,61],{"name":33,"role":38,"phone":39,"phoneExt":26,"email":40},{"name":62,"role":38,"phone":63,"phoneExt":26,"email":44},"Robyn L Wiseman, BS","3045513309",{"type":65,"investigatorFullName":26,"investigatorTitle":26,"investigatorAffiliation":26,"oldNameTitle":26,"oldOrganization":26},"SPONSOR",[67],{"name":68,"class":69},"National Institutes of Health (NIH)","NIH","100422526","phase-4-multimodal-brain-imaging-of-the-neural-effects-of-methylphenidate-in-patients-with-adhd-100422526",false,"NCT04781972","Multimodal Brain Imaging of the Neural Effects of Methylphenidate in Patients With ADHD","Inclusion Criteria:\n\n* right handed\n\nExclusion Criteria:\n\n* pregnant or breast feeding\n* past or current neurological disorder\n* non-ADHD cause of cognitive impairment\n* uncontrolled medical disorder\n* head trauma with loss of consciousness in the last year or any evidence of functional impairment due to and persisting after head trauma\n* having an adverse reaction to methylphenidate, or other stimulant medication\n* having a contraindication to MRI\n* current smoking","ALL","6 Years","40 Years",{"count":80,"type":81},30,"ESTIMATED","INTERVENTIONAL",[84],"PHASE4","The investigators' goal is to develop neuroimaging biomarkers to predict response to treatment with methylphenidate, which then can be used in the development of novel pharmacological treatments for attention-deficit\u002Fhyperactivity disorder (ADHD). The overall objective of this study is to measure the changes in task-related neural activity related to symptoms of ADHD (measured by functional MRI) and brain glutamate levels (measured by magnetic resonance spectroscopy, MRS) after treatment with methylphenidate (MPH). This will be a double-blind crossover of methylphenidate and placebo in adults with ADHD. Participants will complete neuropsychological testing along with fMRI and MRS scans after a single dose of each treatment.",[87],"ADHD - Combined Type","2025-10-15",{"date":90,"type":91},"2025-10-16","ACTUAL",{"date":93,"type":91},"2021-07-27",{"date":95,"type":81},"2029-04-30",{"name":5,"class":6},1]